Signaling pathways
-
BA2977 YH-306Summary: YH-306 is an antitumor agent. - BA2978 OR-1896Summary: OR-1896 is the active long-lived metabolite of Levosimendan.
- BA2979 KYP-2047Summary: KYP-2047 is a potent proline oligopeptidase inhibitor that crosses the blood-brain barrier.
- BA2980 MisetionamideSummary: Misetionamide is an orally available oxathiazine compound.
- BA2982 TricetinSummary: Tricetin is a potent competitive protein interaction (PPI) inhibitor.
- BA2983 BatabulinSummary: Batabulin (T138067) is an antitumor agent that covalently and selectively binds to a subset of beta-microtubule protein isoforms, thereby disrupting microtubule polymerization.
- BA2984 STAT3-IN-13Summary: STAT3-IN-13 is a potent inhibitor.
- BA2985 Thalidomide-O-PEG2-propargylSummary: Thalidomide-O-PEG2-propargyl (E3ligaseLigand-LinkerConjugates32) is a synthesized E3 ligase ligand-linker coupler comprising a Thalidomide-based ligand and a 2-unit PEG linker for technical applications.
- BA2986 CDK9-IN-7Summary: CDK9-IN-7 is a highly potent and selective, orally active inhibitor.
- BA2987 KS106Summary: KS106 is a potent inhibitor.